Human parthenogenetic embryonic stem cells: One potential resource for cell therapy

Science in China, Series C: Life Sciences

Volumn 52, Issue 7, 2009, Pages 599-602

  Hao, Jie ^a,b   Zhu, WanWan ^a   Sheng, Chao ^a   Yu, Yang ^a   Zhou, Qi ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cell therapy; Heterozygosis; Human parthenogenetic embryonic stem cell; Imprinting; Induced differentiation; Therapeutic cloning

Indexed keywords

BIOLOGICAL THERAPY; CELL DIFFERENTIATION; CYTOLOGY; DEGENERATIVE DISEASE; DIABETES MELLITUS; EMBRYONIC STEM CELL; HUMAN; METHODOLOGY; PARTHENOGENESIS; PHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; DIABETES MELLITUS; EMBRYONIC STEM CELLS; HUMANS; NEURODEGENERATIVE DISEASES; PARTHENOGENESIS; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

IPS;

EID: 70350050399     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0096-2     Document Type: Review

References (26)

1. Kroon E, Martinson L A, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol, 2008, 26: 443-452.
2. Lee J P, Jeyakumar M, Gonzalez R, et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med, 2007, 13: 439-447.
3. French A J, Adams C A, Anderson L S, et al. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells, 2008, 26: 485-493.
4. Yu Y, Mai Q, Chen X, et al. Assessment of the developmental competence of human somatic cell nuclear transfer embryos by oocyte morphology classification. Hum Reprod, 2009, 24: 649-657.
5. Kim K, Ng K, Rugg-Gunn P J, et al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell, 2007, 1: 346-352.
6. Lin G, OuYang Q, Zhou X, et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res, 2007, 17: 999-1007.
7. Mai Q, Yu Y, Li T, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res, 2007, 17: 1008-1019.
8. Revazova E S, Turovets N A, Kochetkova O D, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Clon Stem Cells, 2007, 9: 432-449.
9. Kaufman M H, Robertson E J, Handyside A H, et al. Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol, 1983, 73: 249-261.
10. Fang Z F, Gai H, Huang Y Z, et al. Rabbit embryonic stem cell lines derived from fertilized, parthenogenetic or somatic cell nuclear transfer embryos. Exp Cell Res, 2006, 312: 3669-3682.
11. Cibelli J B, Grant K A, Chapman K B, et al. Parthenogenetic stem cells in nonhuman primates. Science, 2002, 295: 819.
12. Sanchez-Pernaute R, Studer L, Ferrari D, et al. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells, 2005, 23: 914-922.
13. Kono T, Obata Y, Yoshimzu T, et al. Epigenetic modifications during oocyte growth correlates with extended parthenogenetic development in the mouse. Nat Genet, 1996, 13: 91-94.
14. Hwang W S, Roh S I, Lee B C, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science, 2005, 308: 1777-1783.
15. Hwang W S, Ryu Y J, Park J H, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science, 2004, 303: 1669-1674.
16. Brivanlou A H, Gage F H, Jaenisch R, et al. Stem cells. Setting standards for human embryonic stem cells. Science, 2003, 300: 913-916.
17. Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem cells. Dev Biol, 2004, 269: 360-380.
18. Loring J F, Rao M S. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells, 2006, 24: 145-150.
19. Allen N D, Barton S C, Hilton K, et al. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development, 1994, 120: 1473-1482.
20. Eckardt S, Dinger T C, Kurosaka S, et al. In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types. Organogenesis, 2008, 4: 33-41.
21. Prawitt D, Enklaar T, Gartner-Rupprecht B, et al. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Nat Genet, 2005, 37: 785-786, author reply 786-787.
22. Humpherys D, Eggan K, Akutsu H, et al. Epigenetic instability in ES cells and cloned mice. Science, 2001, 293: 95-97.
23. Robertson E J, Evans M J, Kaufman M H. X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos. J Embryol Exp Morphol, 1983, 74: 297-309.
24. Zvetkova I, Apedaile A, Ramsahoye B, et al. Global hypomethylation of the genome in XX embryonic stem cells. Nat Genet, 2005, 37: 1274-1279.
25. Hikichi T, Kohda T, Wakayama S, et al. Nuclear transfer alters the DNA methylation status of specific genes in fertilized and parthenogenetically activated mouse embryonic stem cells. Stem Cells, 2008, 26: 783-788.
26. Kim K, Lerou P, Yabuuchi A, et al. Histocompatible embryonic stem cells by parthenogenesis. Science, 2007, 315: 482-486.